5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.07▼ | 2.08▼ | 2.08▼ | 2.09▼ | 2.13▼ |
MA10 | 2.09▼ | 2.09▼ | 2.09▼ | 2.12▼ | 2.15▼ |
MA20 | 2.09▼ | 2.09▼ | 2.10▼ | 2.15▼ | 2.23▼ |
MA50 | 2.11▼ | 2.11▼ | 2.13▼ | 2.17▼ | 3.16▼ |
MA100 | 2.13▼ | 2.13▼ | 2.15▼ | 2.31▼ | 2.00▲ |
MA200 | 2.13▼ | 2.17▼ | 2.18▼ | 3.49▼ | 85.18▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | -0.002▼ | -0.002▼ | -0.007▼ | 0.010▲ |
RSI | 44.781▼ | 45.175▼ | 45.183▼ | 44.009▼ | 42.421▼ |
STOCH | 37.364 | 29.521 | 29.521 | 36.769 | 30.105 |
WILL %R | -83.333▼ | -83.333▼ | -83.333▼ | -76.185▼ | -85.292▼ |
CCI | -84.417 | -105.691▼ | -101.587▼ | -106.325▼ | -130.867▼ |
Friday, August 15, 2025 05:09 AM
Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC). The update note ...
|
Thursday, August 14, 2025 07:21 AM
The company released its 2Q2025 earnings results that showed a loss of $0.79 per share and revenues of $1.4 million, both roughly in line with estimates. The release also showed a good cash balance of ...
|
Wednesday, August 13, 2025 01:29 PM
Initiates Critical Milestone, Launching Phase 3 Trial of PF614 to Advance Next-Generation Opioid Therapy Toward Regulatory Approval Receives $5.3 Million Installment from NIDA To Support Overdose ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 2.10 | 2.1108 | 2.0203 | 2.05 | 112,418 |
14/08/25 | 2.12 | 2.1573 | 2.06 | 2.06 | 99,921 |
13/08/25 | 2.09 | 2.15 | 2.09 | 2.15 | 212,001 |
12/08/25 | 2.01 | 2.1302 | 1.99 | 2.09 | 197,298 |
11/08/25 | 2.14 | 2.1553 | 2.07 | 2.08 | 221,174 |
08/08/25 | 2.10 | 2.25 | 2.05 | 2.18 | 118,055 |
07/08/25 | 2.10 | 2.16 | 2.0404 | 2.08 | 126,991 |
06/08/25 | 2.22 | 2.22 | 2.10 | 2.12 | 141,249 |
05/08/25 | 2.13 | 2.28 | 2.06 | 2.23 | 230,223 |
04/08/25 | 2.01 | 2.19 | 2.00 | 2.15 | 316,035 |
|
|
||||
|
|
||||
|
|